Inari Medical shares are trading lower after the company reported preliminary Q4 and FY revenue guidance. Also, the company issued FY24 revenue guidance.
Portfolio Pulse from Benzinga Newsdesk
Inari Medical's stock is trading lower following the release of their preliminary Q4 and full-year revenue guidance, along with their forecast for FY24 revenue.
January 09, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Inari Medical's shares are down after the company provided preliminary revenue guidance for Q4 and FY, as well as future revenue expectations for FY24.
The negative market reaction is likely due to the revenue guidance not meeting investor expectations, which typically leads to a decrease in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100